International Clinical Trial: A Study to Assess the Long-Term Safety of Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination in Subjects With Dry Eye Disease

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07111013) titled 'A Study to Assess the Long-Term Safety of Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination in Subjects With Dry Eye Disease' on Aug. 6.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Bausch & Lomb Incorporated

Condition: Dry Eye Disease

Intervention: Drug: Lifitegrast/perfluorohexyloctane (PFHO)

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: December 2025

Target Sample Size: 150

To know more, visit https://clinicaltrials.gov/ct2/show/NCT071...